GG
Gleason Group Portfolio holdings
AUM
$923M
1-Year Return
13.47%
This Quarter Return
+11.42%
1 Year Return
+13.47%
3 Year Return
+56.47%
5 Year Return
+87.83%
10 Year Return
–
AUM
$435M
AUM Growth
+$54.6M
(+14%)
Cap. Flow
+$12.1M
Cap. Flow
% of AUM
2.78%
Top 10 Holdings %
Top 10 Hldgs %
81.91%
Holding
239
New
4
Increased
138
Reduced
17
Closed
18
Top Buys
| 1 |
Vanguard Extended Market ETF
VXF
|
$3.52M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
$2.62M |
| 3 |
Schwab US Large- Cap ETF
SCHX
|
$2.57M |
| 4 |
Vanguard Total International Stock ETF
VXUS
|
$1.36M |
| 5 |
Vanguard Total Stock Market ETF
VTI
|
$1.06M |
Top Sells
| 1 |
GSK
GSK
|
$443K |
| 2 |
Dominion Energy
D
|
$362K |
| 3 |
Brown-Forman Class B
BF.B
|
$194K |
| 4 |
Herc Holdings
HRI
|
$189K |
| 5 |
Humana
HUM
|
$147K |
Sector Composition
| 1 | Financials | 1.83% |
| 2 | Consumer Staples | 1.79% |
| 3 | Industrials | 1.55% |
| 4 | Technology | 1.26% |
| 5 | Consumer Discretionary | 1.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
AbbVie
ABBV
$374B
| $18K | ﹤0.01% |
116
+1
| +0.9% | +$155 |
|
152
Diageo
DEO
$61.2B
| $17.4K | ﹤0.01% |
119
+1
| +0.8% | +$146 |
|
153
iShares Morningstar Mid-Cap Value ETF
IMCV
$825M
| $17.4K | ﹤0.01% |
257
+4
| +2% | +$270 |
|
154
iShares MSCI EAFE ETF
EFA
$66.2B
| $17.2K | ﹤0.01% |
229
+3
| +1% | +$226 |
|
155
Comcast
CMCSA
$125B
| $16.9K | ﹤0.01% |
385
+2
| +0.5% | +$88 |
|
156
Eversource Energy
ES
$23.5B
| $16.7K | ﹤0.01% |
271
+3
| +1% | +$185 |
|
157
Orion Group Holdings
ORN
$298M
| $16.7K | ﹤0.01% |
3,382
| – | – |
|
158
Cue Biopharma
CUE
$60.3M
| $15.8K | ﹤0.01% |
6,000
| – | – |
|
159
United Bankshares
UBSI
$5.41B
| $15.7K | ﹤0.01% |
418
+5
| +1% | +$188 |
|
160
Philip Morris
PM
$251B
| $14.6K | ﹤0.01% |
156
+2
| +1% | +$188 |
|
161
Elevance Health
ELV
$70.5B
| $14.5K | ﹤0.01% |
31
| – | – |
|
162
Marsh & McLennan
MMC
$100B
| $14.2K | ﹤0.01% |
75
| – | – |
|
163
Rivian
RIVN
$17.4B
| $14.1K | ﹤0.01% |
600
| – | – |
|
164
NVIDIA
NVDA
$4.04T
| $13.9K | ﹤0.01% |
280
| – | – |
|
165
Vanguard Information Technology ETF
VGT
$99.6B
| $13.7K | ﹤0.01% |
28
-1
| -3% | -$491 |
|
166
Vanguard FTSE Developed Markets ETF
VEA
$171B
| $13.5K | ﹤0.01% |
283
+4
| +1% | +$191 |
|
167
Charles Schwab
SCHW
$168B
| $13K | ﹤0.01% |
190
+1
| +0.5% | +$69 |
|
168
Norfolk Southern
NSC
$62.3B
| $12.5K | ﹤0.01% |
53
+1
| +2% | +$235 |
|
169
Abbott
ABT
$232B
| $12.4K | ﹤0.01% |
112
| – | – |
|
170
iShares S&P Mid-Cap 400 Growth ETF
IJK
$9.2B
| $12.1K | ﹤0.01% |
152
+1
| +0.7% | +$79 |
|
171
Baxter International
BAX
$12.6B
| $11.6K | ﹤0.01% |
300
+2
| +0.7% | +$77 |
|
172
Polaris
PII
$3.32B
| $11.5K | ﹤0.01% |
122
+1
| +0.8% | +$95 |
|
173
Heron Therapeutics
HRTX
$202M
| $11.3K | ﹤0.01% |
+6,670
| New | +$11.3K |
|
174
Wells Fargo
WFC
$254B
| $11.1K | ﹤0.01% |
225
+2
| +0.9% | +$98 |
|
175
TC Energy
TRP
$53.6B
| $11K | ﹤0.01% |
281
+5
| +2% | +$195 |
|